Navigation Links
Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011
Date:12/7/2011

BOONTON, N.J., Dec. 7, 2011 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, announced that Ashleigh Palmer, President and Chief Executive Officer, will be presenting a corporate overview at the 22nd Annual Oppenheimer Healthcare Conference being held in New York City.  Mr. Palmer's live presentation is scheduled to begin at 4:10 p.m. ET on Tuesday, December 13, 2011.

A live webcast of the presentation will be available by logging on to the Investors and Media section under the Events tab of the Unigene web site, http://www.unigene.com. Participants should allow approximately five to 10 minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's web site for 30 days.

About Unigene Laboratories, Inc.:
Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Investor Contact:
Unigene Laboratories, Inc.
Jenene Thomas
VP, Investor Relations and Business Administration
973-265-1107
jthomas@unigene.com

Media Contact:'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Unigene Announces Positive Top-Line Results of Phase 2 Oral PTH Study for the Treatment of Osteoporosis in Postmenopausal Women
2. Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis
3. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
4. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
5. Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
6. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
7. Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
8. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
9. Senesco Technologies, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
11. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Marktech Optoelectronics has introduced the MTE280xxx series, its ... 280 nm wavelength range. This series joins Marktech’s current ... to 405nm. These new devices are suitable for applications ... Mark Campito, Marktech’s CEO states that “what makes this ... that we offer it in one of the largest ...
(Date:9/23/2014)... Dr. Williams says, “Find The Black Box ... a three phase process that can lead to the ... would go far beyond anything previously imagined. First everyone ... healthcare.” , “Every effort to improve the quality of ... progress throughout that system because all of the experts ...
(Date:9/23/2014)... September 23, 2014 Healthcare ... globe will convene at the Society for ... be held October 26-28 in Houston, Texas ... and practice in individualized integrative cancer care. ... nurses, psychologists, nutritionists, naturopaths, acupuncturists, and other ...
(Date:9/23/2014)... Plymouth, MN (PRWEB) September 23, 2014 ... named NimbeLink, a developer of cellular modems ... a finalist in the Startup category for the ... will be held at the Minneapolis Convention Center ... Minnesota companies and individuals who have shown superior ...
Breaking Biology Technology:Marktech Introduces its New Line of Deep UV Emitters 2Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3NimbeLink Named Finalist for 15th Annual Tekne Awards 2NimbeLink Named Finalist for 15th Annual Tekne Awards 3
... KONG, China , July 19 /PRNewswire/ - Aegera Therapeutics ... of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, ... (primary liver cancer). , , ... This study, entitled "A Phase 1-2, Open-Label Study of The ...
... announces that a new market research report is available in its catalogue: , ... Cells Market And Applications. 2009-2015 , , , ... , , REPORT ... The ,Stem Cells Market and Applications: (2009-2015), reviews the latest Stem Cells ...
... PARK, N.C. , July 16 Talecris Biotherapeutics Holdings Corp. (Nasdaq: ... on July 29, 2010 . Due to the pending merger with Grifols, S.A., ... , , , ... Dedication. Innovation. , , , ...
Cached Biology Technology:Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma 2Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma 3Reportlinker Adds Stem Cells Market And Applications. 2009-2015 2Reportlinker Adds Stem Cells Market And Applications. 2009-2015 3Reportlinker Adds Stem Cells Market And Applications. 2009-2015 4Reportlinker Adds Stem Cells Market And Applications. 2009-2015 5Reportlinker Adds Stem Cells Market And Applications. 2009-2015 6Reportlinker Adds Stem Cells Market And Applications. 2009-2015 7Reportlinker Adds Stem Cells Market And Applications. 2009-2015 8Reportlinker Adds Stem Cells Market And Applications. 2009-2015 9Reportlinker Adds Stem Cells Market And Applications. 2009-2015 10Reportlinker Adds Stem Cells Market And Applications. 2009-2015 11Reportlinker Adds Stem Cells Market And Applications. 2009-2015 12Reportlinker Adds Stem Cells Market And Applications. 2009-2015 13Reportlinker Adds Stem Cells Market And Applications. 2009-2015 14Reportlinker Adds Stem Cells Market And Applications. 2009-2015 15Reportlinker Adds Stem Cells Market And Applications. 2009-2015 16Reportlinker Adds Stem Cells Market And Applications. 2009-2015 17Reportlinker Adds Stem Cells Market And Applications. 2009-2015 18Reportlinker Adds Stem Cells Market And Applications. 2009-2015 19Reportlinker Adds Stem Cells Market And Applications. 2009-2015 20Reportlinker Adds Stem Cells Market And Applications. 2009-2015 21Reportlinker Adds Stem Cells Market And Applications. 2009-2015 22Reportlinker Adds Stem Cells Market And Applications. 2009-2015 23Reportlinker Adds Stem Cells Market And Applications. 2009-2015 24Reportlinker Adds Stem Cells Market And Applications. 2009-2015 25Reportlinker Adds Stem Cells Market And Applications. 2009-2015 26Reportlinker Adds Stem Cells Market And Applications. 2009-2015 27Reportlinker Adds Stem Cells Market And Applications. 2009-2015 28Reportlinker Adds Stem Cells Market And Applications. 2009-2015 29Reportlinker Adds Stem Cells Market And Applications. 2009-2015 30Reportlinker Adds Stem Cells Market And Applications. 2009-2015 31Reportlinker Adds Stem Cells Market And Applications. 2009-2015 32Reportlinker Adds Stem Cells Market And Applications. 2009-2015 33
(Date:9/21/2014)... are significantly less likely to report taking iron supplements ... children who are developing normally, a study by researchers ... Low iron intake was associated with a five-fold greater ... was 35 or older at the time of the ... such as obesity hypertension or diabetes. , The research ...
(Date:9/21/2014)... was previously thought, newborn immune T cells may have ... according to a new study led by King,s College ... that of adults, babies may still be able to ... in the journal Nature Medicine . , Our ... of immune cells, including neutrophils which play an important ...
(Date:9/19/2014)... biology professor will study the unique bioelectric signaling system ... benefit people,s health. The OU researcher is working ... to produce the signals used to map the world ... a rate of 500-600 discharges a second throughout their ... fish are extreme, but necessary for survival. , "There ...
Breaking Biology News(10 mins):Mothers of children with autism less likely to have taken iron supplements 2Immune system of newborn babies is stronger than previously thought 2
... 2009, the National Science Foundation (NSF) will host its ... This year,s forum focuses on ecological connectivity and ... In an ecological context, connectivity is defined as the ... and animals among interconnected locations. In this symposium, ...
... Seawater is a complex, dynamic mixture of ... scientists best efforts, presents difficulties in measuring its ... water itself, the calculations scientists employ to measure ... over the years as research techniques and instrumentation ...
... revolutionary new technology developed at The University of Nottingham ... far. Using a scientific technique known as Hydropyrolysis ... able to date chemical fossils discovered in sedimentary rocks ... fossil steroids, remnants of a type of sponge known ...
Cached Biology News:National Science Foundation forum to address ecological connectivity and climate in a changing world 2New equation of state of seawater 2New equation of state of seawater 3Engineering technology pinpoints earliest signs of animal life 2
... Camera hood with 5.6" TFT color screen, without ... system use digital camera with 8.0 mega pixel ... requirements and small budget. View image from large ... specific feature. It is suitable to capture image ...
... The binding specificity and signaling of the ... to be modified by alternative splicing--which has ... SpliceArrays you can perform a classical expression ... the different alternatively spliced forms of the ...
Mouse monoclonal antibody raised against a full length recombinant CSNK2A2. NCBI Entrez Gene ID = CSNK2A2...
... Apoptosis is an evolutionarily conserved form ... cellular process. The central component of ... enzymes called caspases. These enzymes participate ... triggered in response to pro-apoptotic signals and ...
Biology Products: